Advanced search
Publication Cover
Cancer Investigation Volume 5, 1987 - Issue 6
Submit an article Journal homepage
12
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Vinblastine Infusion in Non-Hodgkin's Lymphomas: Lack of Total Cross-Resistance with Vincristine

Don V. Jackson Piedmont Oncology AsSociation and the Oncology Research Center of the Bowman Gray School of Medicine of Wake Forest University Winston-Salem, North Carolina, 27103
,
Charles L. Spurr Piedmont Oncology AsSociation and the Oncology Research Center of the Bowman Gray School of Medicine of Wake Forest University Winston-Salem, North Carolina, 27103
,
M. E. Caponera Piedmont Oncology AsSociation and the Oncology Research Center of the Bowman Gray School of Medicine of Wake Forest University Winston-Salem, North Carolina, 27103
,
D R. White Piedmont Oncology AsSociation and the Oncology Research Center of the Bowman Gray School of Medicine of Wake Forest University Winston-Salem, North Carolina, 27103
,
H. B. Muss Piedmont Oncology AsSociation and the Oncology Research Center of the Bowman Gray School of Medicine of Wake Forest University Winston-Salem, North Carolina, 27103
,
M D. Pavy Piedmont Oncology AsSociation and the Oncology Research Center of the Bowman Gray School of Medicine of Wake Forest University Winston-Salem, North Carolina, 27103
,
G P. Sartiano Piedmont Oncology AsSociation and the Oncology Research Center of the Bowman Gray School of Medicine of Wake Forest University Winston-Salem, North Carolina, 27103
,
P J. Zekan Piedmont Oncology AsSociation and the Oncology Research Center of the Bowman Gray School of Medicine of Wake Forest University Winston-Salem, North Carolina, 27103
&
E A. Hire Piedmont Oncology AsSociation and the Oncology Research Center of the Bowman Gray School of Medicine of Wake Forest University Winston-Salem, North Carolina, 27103
 show all
Pages 535-539 | Published online: 11 Jun 2009

References

  • Jackson DV, Sethi VS, Spurr CL, et al. Intravenous vincristine infusion: Phase I trial. Cancer 1981; 48: 2559–2564
  • Jackson DV, Jr, Paschold EH, Spurr CL, et al. Treatment of advanced non-Hodgkin's lymphoma with vincristine infusion. Cancer 1984; 53: 2601–2606
  • Tiber C, Conrad F, Hagemeister R. Continuous vinblastine for previously treated non-Hodgkin's lymphoma. Proc Am Assoc Cancer Res 1980; 21: 162
  • Kaplon M, Jackson DV, Spurr CL, et al. VP-16-213 vincristme (VCR) infusion in refractory non-Hodgkin's lymphomas (NHL). Proc Am Soc Clin Oncol. 1985; 4: 202
  • Craig J, Jackson D, Powell B, et al. Continuous infusion vincristine (V) as a component of initial chemotherapy for Stage III-IV diffuse histiocytic lymphoma (DHL). Roc Am Assoc Cancer Res 1985; 26: 182
  • Yap HY, Blurnenschein GR, Keating MJ, et al. Vinblastine given as a continuous 5-day infusion in the treatment of refractory advanced breast cancer. Cancer Treat Rep 1980; 64: 279–283
  • Jackson DV, Jr, Bender RA. The clinical pharmacology of the vinca alkaloids epipodophyllotoxins, and waytansix. Clinical Pharmacologp of Anti-Neoplastic Drugs, HM. Pinedo. Elsevier/North Holland Biomedical Press, New York 1978
  • Livingston RB, Carter SK. Single Agents in Cancer Chemotherapy. Plenum Press, New York 1970; 279–377
  • Johnson IS, Armtrong JG, Gorman M, et al. The vinca alkaloids: A new class of oncolytic agents. Cancer Res 1963; 23: 1390–1427
  • Carbone PP, Bono V, Frei E, III, et al. Clinical studies with vincristine. Blood 1963; 21: 640–647
  • Holland JF, Scharlau C, Gailani S, et al. Vincristine treatment of advanced cancer: a cooperative study of 392 cases. Cancer Res 1973; 33: 1258–1264
  • Miaskowski C, Vogl S, Kaplan B. Safety of continuous infusion of vinca alkaloids (vindesine and vinblastine) via peripheral vein. Proc Am Assoc Cancer 1984; 25: 364

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.